CLINICAL RESULTS OF TWO PATIENTS WITH LATE RECURRENCE OF RENAL CELL CARCINOMA AFTER LONG TERM OBSERVATION WITHOUT TREATMENT
Author:
Affiliation:
1. Department of Urology, Toranomon Hospital
Publisher
Japanese Urological Association
Subject
Urology
Link
https://www.jstage.jst.go.jp/article/jpnjurol/111/2/111_39/_pdf
Reference11 articles.
1. 1) Lane BR, Abouassaly R, Gao T, Weight CJ, Hernandez AV, Larson BT, Kaouk JH, Gill IS and Campbell SC: Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer, 116, 3119-3126, 2010.
2. 2) Fujii Y, Ikeda M, Kurosawa K, Tabata M, Kamigaito T, Hosoda C and Okaneya T: Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. Int J Clin Oncol., 20, 802-807, 2015.
3. 3) Schwartz M: A biomathematical approach to clinical tumor growth. Cancer, 14, 1272-1294, 1961.
4. 5) Tanis PJ, van der Gaag NA, Busch OR, van Gulik TM and Gouma DJ: Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg., 96, 579-592, 2009.
5. 6) Volk A, Kersting S, Konopke R, Dobrowolski F, Franzen S, Ockert D, Grutzmann R, Saeger HD and Bergert H: Surgical therapy of intrapancreatic metastasis from renal cell carcinoma. Pancreatology, 9, 392-397, 2009.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3